Dyadic and CIMV to collaborate on 2nd generation biofuel and bio-based chemical technologies
Green Car Congress
AUGUST 5, 2014
Dyadic utilizes an integrated technology platform based on its patented and proprietary C1 microorganism, which enables the development and large scale manufacture of low-cost enzymes and other proteins for diverse market opportunities. The C1 expression system can also be used to screen for the discovery of novel genes.
Let's personalize your content